Document is current
Any future updates will be listed below
-
Authors
Minutolo, Roberto
Simeon, Vittorio
De Nicola, Luca
Chiodini, Paolo
Galiero, Raffaele
Rinaldi, Luca
Caturano, Alfredo
Vetrano, Erica
Sardu, Celestino
Marfella, Raffaele
Sasso, Ferdinando Carlo
,
Amelia, U.
Acierno, C.
Calatola, P.
Carbonara, O.
Caturano, A.
Conte, G.
Corigliano, G.
Corigliano, M.
D’Urso, R.
De Matteo, A.
De Nicola, L.
De Rosa, N.
Del Vecchio, E.
Di Giovanni, G.
Gatti, A.
Gentile, S.
Gesuè, L.
Improta, L.
Lampitella Jr, A.
Lampitella, A.
Lanzilli, A.
Lascar, N.
Masi, S.
Mattei, P.
Mastrilli, V.
Memoli, P.
Minutolo, R.
Nasti, R.
Pagano, A.
Pentangelo, M.
Pisa, E.
Rossi, E.
Sasso, F. C
Sorrentino, S.
Torella, R.
Troise, R.
Trucillo, P.
Turco, A. A.
Turco,, S.
Zibella, F.
Zirpoli, L.
-
Funding
Funding for this research was provided by:
Ministero dell’Università e della Ricerca (ID: 2007PSYLRX_003)
- License Information
-
More Information
Article History
Received: 8 June 2024
Accepted: 21 July 2024
First Online: 5 August 2024
Declarations
:
: Roberto Minutolo has been member of Advisory Boards for Astellas, and invited speaker at meetings supported by Amgen, Astellas, Vifor Pharma, Bayer, Astrazeneca. Luca De Nicola has received fees for scientific consultation and/or lectures by Astellas, AstraZeneca, Bayer, Novo. Ferdinando Carlo Sasso has been member of Advisory Boards for Boehringer and for Ely-Lilly and has received fees for scientific consultation and/or lectures by Jansen, Roche Diagnostics, Novo Nordisk, Sanofi, MSD, Astrazeneca. Vittorio Simeon, Paolo Chiodini, Raffaele Galiero, Luca Rinaldi, Raffaele Marfella, Celestino Sardu, have no conflict of interest to disclose.
